Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.71 - $2.86 $6,238 - $25,127
8,786 Added 48.94%
26,737 $24,000
Q2 2021

Aug 13, 2021

SELL
$4.7 - $16.7 $309,683 - $1.1 Million
-65,890 Reduced 78.59%
17,951 $186,000
Q1 2021

May 12, 2021

BUY
$3.79 - $9.78 $5,302 - $13,682
1,399 Added 1.7%
83,841 $641,000
Q4 2020

Feb 11, 2021

BUY
$3.47 - $4.52 $2,633 - $3,430
759 Added 0.93%
82,442 $311,000
Q3 2020

Nov 16, 2020

BUY
$3.55 - $9.99 $19,269 - $54,225
5,428 Added 7.12%
81,683 $290,000
Q2 2020

Aug 14, 2020

BUY
$4.75 - $15.38 $362,211 - $1.17 Million
76,255 New
76,255 $705,000

About Nemaura Medical Inc.


  • Ticker NMRD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,102,900
  • Description
  • Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...
More about NMRD
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.